Detalhe da pesquisa
1.
Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.
Hematol Oncol
; 31(2): 96-102, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22961993
2.
Staging systems and prognostic factors as a guide to therapeutic decisions in multiple myeloma.
Semin Hematol
; 46(2): 110-7, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19389494
3.
Efficacy-safety of Facilitated Subcutaneous Immunoglobulin in Immunodeficiency Due to Hematological Malignancies. A Single-Center Retrospective Analysis.
Anticancer Res
; 38(7): 4187-4191, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29970548
4.
An imatinib-treated FIL1P1-PDGFRα chronic eosinophilic leukemia transforming to erythroid blast crisis: a case report.
Ann Hematol
; 91(5): 785-787, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21881824
5.
Serum soluble TACI, a BLyS receptor, is a powerful prognostic marker of outcome in chronic lymphocytic leukemia.
Biomed Res Int
; 2014: 159632, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25162001
6.
Prognostic significance of serum free light chains in chronic lymphocytic leukemia.
Adv Hematol
; 2013: 359071, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24288537
7.
New evidence of gene inactivation by aberrant DNA-Methylation in T-cell leukemia, with treatment implications.
Leuk Res
; 50: 29-30, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27649494
8.
Novel M-component based biomarkers in Waldenström's macroglobulinemia.
Clin Lymphoma Myeloma Leuk
; 11(1): 164-7, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21454223
9.
CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL).
Clin Lymphoma Myeloma Leuk
; 11(1): 99-102, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21454203